![Lauren Barnes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lauren Barnes
Direktor/Vorstandsmitglied bei
ASCELIA PHARMA AB
Profil
Lauren G.
Barnes is currently an Independent Director at Ascelia Pharma AB since 2020, a Director at Ossium Health, Inc. since 2024, and SVP-Strategic Market Development & Access at Blueprint Medicines Corp.
since 2023.
Former roles include Chairman at Cancer Support Community from 2013 to 2024, Vice President at Vertex Pharmaceuticals, Inc. from 2015 to 2019, and Senior Vice President at Avalere Health LLC from 2005 to 2015.
Education includes undergraduate studies at The Johns Hopkins University and graduate studies at Johns Hopkins Bloomberg School of Public Health.
Aktive Positionen von Lauren Barnes
| Unternehmen | Position | Beginn |
|---|---|---|
| ASCELIA PHARMA AB | Direktor/Vorstandsmitglied | 06.05.2020 |
| BLUEPRINT MEDICINES CORPORATION | Corporate Officer/Principal | 01.04.2019 |
Ossium Health, Inc.
 Ossium Health, Inc. BiotechnologyHealth Technology Develops first-of-its-kind solution for processing, banking and deploying bone marrow derived cell therapies | Direktor/Vorstandsmitglied | 01.02.2024 |
Ehemalige bekannte Positionen von Lauren Barnes
| Unternehmen | Position | Ende |
|---|---|---|
Cancer Support Community
 Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides cancer support services | Vorsitzender | 01.02.2024 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01.04.2019 |
Avalere Health LLC
 Avalere Health LLC Miscellaneous Commercial ServicesCommercial Services Provides healthcare advisory services | Corporate Officer/Principal | 01.02.2015 |
Ausbildung von Lauren Barnes
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
33
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalere Health LLC
Avalere Health LLC Miscellaneous Commercial ServicesCommercial Services Provides healthcare advisory services | Commercial Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Johns Hopkins Bloomberg School of Public Health
 Johns Hopkins Bloomberg School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascelia Pharma AB
 Ascelia Pharma AB Pharmaceuticals: MajorHealth Technology Operates as oncology-dedicated drug development company, which develops novel drugs to improve life expectancy | Health Technology |
Cancer Support Community
Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides cancer support services | Commercial Services |
Ossium Health, Inc.
Ossium Health, Inc. BiotechnologyHealth Technology Develops first-of-its-kind solution for processing, banking and deploying bone marrow derived cell therapies | Health Technology |
